KEY FEATURES
| Full Name | Nuclear Factor Kappa B2 |
|---|---|
| Synonym | LYT-10; H2TF1; Lymphocyte translocation chromosome 10; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B-Cells 2(p49/P100); Nuclear factor NF-kappa-B p52 |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human NFkB2 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human NFkB2. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human NFkB2 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human NFkB2, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human NFkB2. You can calculate the concentration of Human NFkB2 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human NFkB2 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.03 | 2.37 | 8.73 | 1.09 | 2.34 | 8.71 |
| Standard deviation | 0.06 | 0.14 | 0.42 | 0.06 | 0.1 | 0.33 |
| CV(%) | 5.94 | 5.7 | 4.77 | 5.65 | 4.07 | 3.82 |
RECOVERY
The recovery of Human NFkB2 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 93-104 | 98 |
| EDTA plasma (n=8) | 92-106 | 100 |
| Cell culture media (n=8) | 88-100 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human NFkB2 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with NFKB2 ELISA Kits
| RELA ELISA Kit | publications with NFKB2 and RELA |
| RELB ELISA Kit | publications with NFKB2 and RELB |
| TNF ELISA Kit | publications with NFKB2 and TNF |
| NFKB1 ELISA Kit | publications with NFKB2 and NFKB1 |
| IKBKB ELISA Kit | publications with NFKB2 and IKBKB |
| CHUK ELISA Kit | publications with NFKB2 and CHUK |
| BCL3 ELISA Kit | publications with NFKB2 and BCL3 |
| BTRC ELISA Kit | publications with NFKB2 and BTRC |
Pathways associated with NFKB2 ELISA Kit
| Activated TLR4 Signalling Pathway | Activated TLR4 Signalling Pathway |
| Alternative NF-kappaB Pathway | Alternative NF-kappaB Pathway |
| C-type Lectin Receptors (CLRs) Pathway | C-type Lectin Receptors (CLRs) Pathway |
| CLEC7A (Dectin-1) Signaling Pathway | CLEC7A (Dectin-1) Signaling Pathway |
| Cytokine Signaling In Immune System Pathway | Cytokine Signaling In Immune System Pathway |
| Cytosolic Sensors Of Pathogen-associated DNA Pathway | Cytosolic Sensors Of Pathogen-associated DNA Pathway |
| DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production Pathway | DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production Pathway |
| DNA Damage Response (only ATM Dependent) Pathway | DNA Damage Response (only ATM Dependent) Pathway |
| Dectin-1 Mediated Noncanonical NF-kB Signaling Pathway | Dectin-1 Mediated Noncanonical NF-kB Signaling Pathway |
| Disease Pathway | Disease Pathway |
Diseases associated with NFKB2 ELISA Kit
| Necrosis | publications with NFKB2 and Necrosis |
| Inflammation | publications with NFKB2 and Inflammation |
| Cell Transformation, Neoplastic | publications with NFKB2 and Cell Transformation, Neoplastic |
| Breast Neoplasms | publications with NFKB2 and Breast Neoplasms |
| Cardiovascular Diseases | publications with NFKB2 and Cardiovascular Diseases |
| Lung Diseases | publications with NFKB2 and Lung Diseases |
| Chromosome Aberrations | publications with NFKB2 and Chromosome Aberrations |
| Nervous System Diseases | publications with NFKB2 and Nervous System Diseases |
| Lung Neoplasms | publications with NFKB2 and Lung Neoplasms |
| Kidney Diseases | publications with NFKB2 and Kidney Diseases |
Organs/Tissues associated with NFKB2 ELISA Kit
| Blood | publications with NFKB2 and Blood |
| Bone | publications with NFKB2 and Bone |
| Bone Marrow | publications with NFKB2 and Bone Marrow |
| Lung | publications with NFKB2 and Lung |
| Brain | publications with NFKB2 and Brain |
| Spleen | publications with NFKB2 and Spleen |
| Prostate | publications with NFKB2 and Prostate |
| Lymph | publications with NFKB2 and Lymph |
| Lymph Node | publications with NFKB2 and Lymph Node |
| Kidney | publications with NFKB2 and Kidney |